Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:abuseDeterrent |
yes
|
| gptkbp:activeIngredient |
gptkb:oxycodone
|
| gptkbp:broadcastOn |
Schedule I (Canada)
|
| gptkbp:controlledSubstanceSchedule |
yes
|
| gptkbp:countryOfOperation |
gptkb:Canada
|
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
OxyNeo
|
| gptkbp:indication |
pain management
|
| gptkbp:manufacturer |
gptkb:Purdue_Pharma
|
| gptkbp:mechanismOfAction |
opioid receptor agonist
|
| gptkbp:releaseYear |
2012
|
| gptkbp:replacedBy |
gptkb:OxyContin
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Purdue_Pharma
|
| gptkbp:bfsLayer |
6
|